Why the study?
Guidance on diabetes-related hyperglycaemic emergencies mainly focuses on preserved renal function or early-stage CKD, leaving a clinical need for recommendations tailored to stage 4 and 5 CKD.
How should diabetes-related hyperglycaemic emergencies be managed in patients with advanced chronic kidney disease?
How should diabetes-related hyperglycaemic emergencies be managed in patients with advanced chronic kidney disease?
This review provides a proposed management algorithm for the complex presentation of diabetic emergencies in patients with advanced chronic kidney disease.
Atypical DKA/HHS presentations warrant vigilance in stage 4-5 CKD; review leaves open optimal management strategies.
AIMS: Despite the substantial progress in the management of diabetes mellitus (DM), chronic kidney disease (CKD) remains one of the most common complications. Although uncommon, diabetic emergencies [diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS)] can still occur in stage 4 and 5 CKD, at times with less typical clinical manifestations due to the altered pathophysiology, presence of chronic metabolic acidosis and effect of haemodialysis on glycaemic control and metabolic parameters. The purpose of this article is to review the current literature and provide recommendations for the diagnosis and treatment of DKA, euglycaemic DKA and HHS in people with advanced CKD. METHODS AND RESULTS: Guidance on the management of diabetes-related emergencies mainly focuses on individuals with preserved renal function or early-stage CKD. Existing literature is limited, and recommendations are based on expert opinions and case reports. Given the clinical need for amended guidelines for this population, we are proposing a management algorithm for DKA and HHS based on clinical and metabolic parameters. CONCLUSIONS: In this review article, we propose treatment algorithms for diabetes-related hyperglycaemic emergencies in people with advanced CKD. Further research is needed to validate our proposed algorithms.
No takes yet. Share an insight, caveat, or question.
Stathi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: